Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
05/10/2023 22:58
Oct 6 (Reuters) - Paradigm Biopharmaceuticals Ltd
PAR.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON NEW CLINICAL
DATA
Source text for Eikon: ID:nASX7SLLYs
Further company coverage: PAR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt